A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory…

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, November 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy: 2 policy sources

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 52 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

Cyramza for Advanced GC or GEJ Adenocarcinoma – Details

Cited by Canadian Agency for Drugs and Technologies in Health on 01 Jun 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Oesophago-gastric cancer: assessment and management in adults : Full guideline

Cited by National Institute for Health and Care Excellence on 26 Mar 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Oesophago-gastric cancer: assessment and management in adults : Appendix F

Cited by National Institute for Health and Care Excellence on 16 Jan 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.